CRTAC1 and central nervous system cancer: CRTAC1, an extracellular matrix protein initially isolated from human chondrogenic tissue [32], was found to be present at lower levels in the plasma of glioma patients compared with nonglioma patients, and in glioma tissue compared with tumor‐free brain tissue [33].